Indolamine 2,3-dioxygenase regulation and neuropsychiatric symptoms

Psychoneuroendocrinology

Volumn 38, Issue 9, 2013, Pages 1829-1830

  Loftis, Jennifer M ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anxiety; Cytokine; Depression; Inflammation; Tryptophan

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; KYNURENINE; PROTEASOME; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN;

ANXIETY; DEPRESSION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; IMMUNOLOGICAL TOLERANCE; INTERLEUKIN 6 GENE; LETTER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SEROTONIN TRANSPORTER GENE;

ANXIETY; CYTOKINE; DEPRESSION; INFLAMMATION; TRYPTOPHAN;

ANTIVIRAL AGENTS; ANXIETY; DEPRESSION; FATIGUE; HEPATITIS C, CHRONIC; HUMANS; INDEL MUTATION; INTERFERON-ALPHA; INTERLEUKIN-6; POINT MUTATION; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84883655657     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.05.020     Document Type: Letter

References (8)

1. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
2. Fallarino F., Grohmann U., Puccetti P. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur. J. Immunol. 2012, 42:1932-1937.
3. α+ dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 2001, 167:708-714.
4. Kiank C., Zeden J.P., Drude S., Domanska G., Fusch G., Otten W., Schuett C. Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PLoS ONE 2010, 5:e11825.
5. Kim H., Chen L., Lim G., Sung B., Wang S., McCabe M.F., Rusanescu G., Yang L., Tian Y., Mao J. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J. Clin. Invest. 2012, 122:2940-2954.
6. Loftis J.M., Hauser P. The phenomenology and treatment of interferon-induced depression. J. Affect. Disord. 2004, 82:175-190.
7. Raison C.L., Dantzer R., Kelley K.W., Lawson M.A., Woolwine B.J., Vogt G., Spivey J.R., Saito K., Miller A.H. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 2010, 15:393-403.
8. Udina M., Moreno-España J., Navinés R., Giménez D., Langohr K., Gratacòs M., Capuron L., de la Torre R., Solà R., Martín-Santos R. Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 2013, April 6, [Epub ahead of print].